As usual, Julie Ferris-Tillman had a full evening planned after leaving her office. By day, she’s vice president of a public ...
A new study has found that the risk of serious bleeding is similar when taking the blood thinners apixaban and dabigatran compared to aspirin. However, the blood thinner rivaroxaban has a higher ...
2d
Daily Express US on MSNScientists issue chilling warning over 'common' injury that could 'double' dementia riskAn injury that is often overlooked by many could actually double your risk of developing dementia, according to a stark new ...
Scientists say people who have experienced a brain bleed should be regularly screened for cognitive impairment.
This important study examines the role of pericytes in patterning the zebrafish blood-brain barrier (BBB) and controlling its permeability. Using pdgfrb mutant zebrafish models lacking brain pericytes ...
Georgia College and State University senior William Penn survived a life-threatening brain hemorrhage at age 10 and has since regained his health after intensive therapy.
A systematic review and meta-analysis of nine trials comparing non-vitamin K oral anticoagulants with low-dose aspirin revealed a link between rivaroxaban and higher rates of major bleeding and ...
4d
Daily Express US on MSNSerious warning over an injury which 'may double' risk of developing dementiaResearchers from Weill Cornell Medicine continue to find a higher risk of dementia among those who suffer 'intracranial ...
Weill Cornell Medicine researchers have found that intracranial hemorrhages, or "brain bleeds" caused by a ruptured blood vessel in the brain, double a person’s risk of developing dementia later in ...
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.
The benefit of direct oral anticoagulants on stroke risk in patients with prior intracerebral hemorrhage and atrial ...
Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results